SOHO State of the Art Updates and Next Questions: T-Cell–Directed Immune Therapies for Multiple Myeloma: Chimeric Antigen Receptor–Modified T Cells and Bispecific T-Cell–Engaging Agents

Title
SOHO State of the Art Updates and Next Questions: T-Cell–Directed Immune Therapies for Multiple Myeloma: Chimeric Antigen Receptor–Modified T Cells and Bispecific T-Cell–Engaging Agents
Authors
Keywords
Bi-specific T cell-engaging agents, CAR-T cells, Immunotherapy, Multiple Myeloma
Journal
Clinical Lymphoma Myeloma & Leukemia
Volume 19, Issue 9, Pages 537-544
Publisher
Elsevier BV
Online
2019-08-08
DOI
10.1016/j.clml.2019.08.002

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now